PATENT CLAIM ANALYSIS

Application Number: 16103375
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "253130"]

Abstract:
The disclosure provides compounds of Formulae (I)-(IX). The disclosed compounds are capable of inhibiting a mammalian SHMT. Compounds of the disclosure have numerous uses, such as for treatment of cancer or autoimmue disorders.

Claim (Index 15):
The method of  claim 1 , wherein the method is a method for treating a cancer selected from pediatric leukemia, adult leukemia, lymphoma, lung cancer, non-small cell lung cancer, mesothelioma, breast cancer, colon cancer, liver cancer, stomach cancer, prostate cancer, pancreatic cancer, ovarian cancer, uterine cancer, female genital tract cancer, bladder cancer, head and neck cancer, osteosarcoma, or trophoblastic neoplasms.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.30303
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15705200', '15552442', '14346359', '13891067', '13227130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8162887798472309
- 35 USC 102 Novelty (BERT): 0.6283098024782808
- Combined Prediction Score: 0.7974908821103359
- Mean Citation Score: 448.057326
- Max Citation Score: 794.0231
- Similarity Product: 509.8760530192554

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test